C07F 9/4461
The amide moiety containing a substituent or a structure which is considered
Official title: {the amide moiety containing a substituent or a structure which is considered as characteristic}
C07F9/4461 (The amide moiety containing a substituent or a structure which is considered) appears on 136 US grants and 53 published applications in this corpus.
Search patents in C07F- Granted patents
- 136
- Published applications
- 53
- Assignees
- 71
- Inventors
- 266
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 7 | 0 |
| 1977 | 2 | 0 |
| 1978 | 3 | 0 |
| 1979 | 4 | 0 |
| 1980 | 4 | 0 |
| 1981 | 4 | 0 |
| 1982 | 2 | 0 |
| 1983 | 2 | 0 |
| 1984 | 3 | 0 |
| 1985 | 5 | 0 |
| 1986 | 0 | 0 |
| 1987 | 6 | 0 |
| 1988 | 0 | 0 |
| 1989 | 4 | 0 |
| 1990 | 4 | 0 |
| 1991 | 2 | 0 |
| 1992 | 4 | 0 |
| 1993 | 6 | 0 |
| 1994 | 0 | 0 |
| 1995 | 3 | 0 |
| 1996 | 8 | 0 |
| 1997 | 2 | 0 |
| 1998 | 5 | 0 |
| 1999 | 3 | 0 |
| 2000 | 7 | 0 |
| 2001 | 2 | 0 |
| 2002 | 4 | 2 |
| 2003 | 2 | 2 |
| 2004 | 1 | 2 |
| 2005 | 2 | 1 |
| 2006 | 1 | 4 |
| 2007 | 0 | 2 |
| 2008 | 1 | 0 |
| 2009 | 1 | 2 |
| 2010 | 2 | 2 |
| 2011 | 0 | 0 |
| 2012 | 1 | 2 |
| 2013 | 4 | 5 |
| 2014 | 1 | 2 |
| 2015 | 4 | 2 |
| 2016 | 1 | 1 |
| 2017 | 1 | 1 |
| 2018 | 2 | 3 |
| 2019 | 1 | 2 |
| 2020 | 1 | 1 |
| 2021 | 1 | 3 |
| 2022 | 2 | 5 |
| 2023 | 2 | 2 |
| 2024 | 5 | 3 |
| 2025 | 2 | 1 |
| 2026 | 2 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Phosphoantigen prodrug compounds1 Sep 2026US 12,723,055 B2The University of Birmingham
- Inhibitors of phospholipid synthesis and methods of use3 Feb 2026US 12,540,115 B2The Board of Trustees of the Leland Stanford Junior University
- Heterocyclic THR-β receptor agonist compound and preparation method and use therefor5 Aug 2025US 12,378,268 B2Hepagene Therapeutics (HK) Limited
- Cannabinoid derivatives18 Mar 2025US 12,252,503 B2Canopy Growth Corporation
- Chemoselective thiol-conjugation with alkene or alkyne-phosphonamidates24 Dec 2024US 12,171,837 B2Forschungsverbund Berlin E.V.
- Novel phosphoantigen prodrug compound and use thereof8 Oct 2026US 2026/0306541 A1
- Prodrugs of dimethoxyphenylalkylamine activators of serotonin receptors23 Jul 2026US 2026/0207636 A1
- Modulator for promoting binding of butyrophilin 3a1/2a123 Jul 2026US 2026/0207637 A1Unicet Biotech Co. LLC.
- Chemoselective thiol-conjugation with alkene or alkyne-phosphonamidates20 Mar 2025US 2025/0090672 A1Forschungsverbund Berlin E.V.
- Synthesis of backbone modified morpholino oligonucleotides and chimeras using phosphoramidite chemistry5 Dec 2024US 2024/0400590 A1The Regents of the University of Colorado, a body corporate
Most cited
By later US patents
- Inhibitors of NAALADase enzyme activity97US 5,795,877 AGuilford Pharmaceuticals Inc. · 1998
- Class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof75US 6,511,990 B1Sloan-Kettering Institute for Cancer Research · 2003
- Phosphoramidate derivatives73US 5,863,536 AGuilford Pharmaceuticals Inc. · 1999
- Naaladase inhibitors67US 5,968,915 AGuilford Pharmaceuticals Inc. · 1999
- Certain phosphonomethyl-pentanedioic acid derivatives thereof66US 5,672,592 AGuilford Pharmaceuticals Inc. · 1997